A Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in AIS Subjects

Clinical trial NCT05403866 · COMPLETED

Trial details

NCT number: NCT05403866
Sponsor: Lumosa Therapeutics Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Ischemic Stroke

Start date: 2022-08-17
Primary completion: 2025-05-23
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.